Jump to content
 







Main menu
   


Navigation  



Main page
Contents
Current events
Random article
About Wikipedia
Contact us
Donate
 




Contribute  



Help
Learn to edit
Community portal
Recent changes
Upload file
 








Search  

































Create account

Log in
 









Create account
 Log in
 




Pages for logged out editors learn more  



Contributions
Talk
 



















Contents

   



(Top)
 


1 Notes  














TA-NIC






Français
 

Edit links
 









Article
Talk
 

















Read
Edit
View history
 








Tools
   


Actions  



Read
Edit
View history
 




General  



What links here
Related changes
Upload file
Special pages
Permanent link
Page information
Cite this page
Get shortened URL
Download QR code
Wikidata item
 




Print/export  



Download as PDF
Printable version
 
















Appearance
   

 






From Wikipedia, the free encyclopedia
 


TA-NIC is a proprietary vaccine in development similar to TA-CD but being used to create human anti-nicotine antibodies in a person to destroy nicotine in the human body so that it is no longer effective.[1]

TA-NIC is a vaccine in development as an aid to quitting smoking in motivated patients. TA-NIC is an immunotherapeutic vaccine similar in concept to TA-CD, designed to raise anti-nicotine antibodies. The antibodies bind to nicotine molecules in the patient's blood stream, reducing the rate and quantity of nicotine entry into the brain and thus reducing the positive reinforcement and addiction associated with nicotine and cigarette smoking. It is expected that the reduction of the positive reinforcement will in turn reduce the desire to smoke or use other tobacco products. Treatment with TA-NIC is expected to be part of a comprehensive smoking cessation management program that includes other supportive measures.

Results from its clinical trials are not publicly available, although one of its developers, Thomas Kosten, disclosed in an email that the vaccine was not found to be effective enough to continue development.[2]

Notes[edit]

  1. ^ "CelticPharma: TA-NIC Nicotine Dependence". Archived from the original on 2009-12-06. Retrieved 2009-10-27.
  • ^ Truong, Thanh Thuy; Kosten, Thomas R. (15 March 2022). "Current status of vaccines for substance use disorders: A brief review of human studies". Journal of the Neurological Sciences. 434: 120098. doi:10.1016/j.jns.2021.120098. ISSN 0022-510X.
  • t
  • e
  • t
  • e

  • Retrieved from "https://en.wikipedia.org/w/index.php?title=TA-NIC&oldid=1179904353"

    Categories: 
    Vaccines against drugs
    Vaccines
    Tobacco
    Smoking
    Vaccine stubs
    Nervous system drug stubs
    Hidden categories: 
    Articles with short description
    Short description matches Wikidata
    Wikipedia articles in need of updating from November 2021
    All Wikipedia articles in need of updating
    Articles needing additional references from February 2023
    All articles needing additional references
    Articles with multiple maintenance issues
    All stub articles
     



    This page was last edited on 13 October 2023, at 05:45 (UTC).

    Text is available under the Creative Commons Attribution-ShareAlike License 4.0; additional terms may apply. By using this site, you agree to the Terms of Use and Privacy Policy. Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc., a non-profit organization.



    Privacy policy

    About Wikipedia

    Disclaimers

    Contact Wikipedia

    Code of Conduct

    Developers

    Statistics

    Cookie statement

    Mobile view



    Wikimedia Foundation
    Powered by MediaWiki